New Novartis data show Cosentyx demonstrated sustained superiority in skin clearance (PASI 90) versus Stelara at Week 52
Source URL: https://qa1.novartis.us/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52-0
List of links present in page
- https://qa1.novartis.us/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52-0